← Back to Search

Early Appendectomy for Appendicitis

Phase 4
Waitlist Available
Led By Steven W. Bruch, M.D.
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years; (although this appears longer than trial duration, study completion date is based on last 2 year survey turned in, and medical record analysis looked a full two years per participant which extended a bit longer.)
Awards & highlights

Study Summary

This trial is testing which of 3 treatments for complicated appendicitis is most cost effective in children.

Eligible Conditions
  • Appendicitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years; (although this appears longer than trial duration, study completion date is based on last 2 year survey turned in, and medical record analysis looked a full two years per participant which extended a bit longer.)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years; (although this appears longer than trial duration, study completion date is based on last 2 year survey turned in, and medical record analysis looked a full two years per participant which extended a bit longer.) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Overall Cost of Care
Secondary outcome measures
Complications
Duration of Antibiotic Therapy
Length of Stay
+5 more

Side effects data

From 2020 Phase 4 trial • 40 Patients • NCT03159754
25%
Abdominal Pain
25%
Abscess and Drain Placement
100%
80%
60%
40%
20%
0%
Study treatment Arm
No Appendectomy
Early Appendectomy
Interval Appendectomy

Trial Design

3Treatment groups
Experimental Treatment
Group I: No AppendectomyExperimental Treatment1 Intervention
Group II: Interval AppendectomyExperimental Treatment2 Interventions
Group III: Early AppendectomyExperimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Early Appendectomy
2017
Completed Phase 4
~40
Interval Appendectomy
2017
Completed Phase 4
~40
Piperacillin
FDA approved

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,794 Previous Clinical Trials
6,373,876 Total Patients Enrolled
1 Trials studying Appendicitis
23 Patients Enrolled for Appendicitis
Steven W. Bruch, M.D.Principal InvestigatorUniversity of Michigan

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025